Quick10K

⚲

Cell Medx

Filings

S-1	2021-03-04	Public Filing
10-Q	2021-02-28	Filed 2021-04-09
10-Q	2020-11-30	Filed 2021-01-14
10-Q	2020-08-31	Filed 2020-10-15
10-K	2020-05-31	Filed 2020-09-15
10-Q	2020-02-29	Filed 2020-04-14
10-Q	2019-11-30	Filed 2020-01-14
10-Q	2019-08-31	Filed 2019-10-15
10-K	2019-05-31	Filed 2019-09-06
10-Q	2019-02-28	Filed 2019-04-22
10-Q	2018-11-30	Filed 2019-01-14
10-Q	2018-08-31	Filed 2018-10-15
10-K	2018-05-31	Filed 2018-09-13
10-Q	2018-02-28	Filed 2018-04-16
10-Q	2017-11-30	Filed 2018-01-16
10-Q	2017-08-31	Filed 2017-10-17
10-K	2017-05-31	Filed 2017-08-29
10-Q	2017-02-28	Filed 2017-04-14
10-Q	2016-11-30	Filed 2017-01-17
10-Q	2016-08-31	Filed 2016-10-17
10-K	2016-05-31	Filed 2016-09-13
10-Q	2016-02-29	Filed 2016-04-14
10-Q	2015-11-30	Filed 2016-01-14
10-Q	2015-08-31	Filed 2015-10-15
10-K	2015-05-31	Filed 2015-09-03
10-Q	2015-02-28	Filed 2015-04-14
10-Q	2014-11-30	Filed 2015-01-14
10-Q	2014-08-31	Filed 2014-10-09
10-K	2014-05-31	Filed 2014-08-26
10-Q	2014-02-28	Filed 2014-04-18
10-Q	2013-11-30	Filed 2014-01-13
10-Q	2013-08-31	Filed 2013-10-03
10-Q	2013-02-28	Filed 2013-04-15
10-Q	2012-11-30	Filed 2013-01-16
10-Q	2012-08-31	Filed 2012-10-15
10-K	2012-05-31	Filed 2012-10-11
10-Q	2012-02-29	Filed 2012-04-09
10-Q	2011-11-30	Filed 2012-03-02
10-Q	2011-08-31	Filed 2011-10-17
10-K	2011-05-31	Filed 2011-09-21

Reports

8-K	2020-07-30
8-K	2020-06-08
8-K	2020-05-06
8-K	2020-01-29
8-K	2019-06-24
8-K	2019-03-21
8-K	2018-12-27
8-K	2018-05-07
8-K	2018-03-23

Cell Medx Financials

CMXC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($'000)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-11-30	2019-02-28	2019-05-31
Cash	0	0	30	24	24	19	13	11	5	2	1	1	0	0	29	1	7	2	15	28	38	118	9	67	326	108	24	8	24	131	57
Accounts Receivable
Inventory															1	1	1	1	1	5	1	4	3	8	22	29	30	11	60	64	73
PP&E																28	26	35	32	207	207	207	256	194	154	116	79		2	1	1
Assets	0	0	30	24	24	19	13	11	5	2				105	59	47	45	48	167	269	252	379	335	294	532	376	163	45	95	222	191
Accounts Payable						0	0		0	0	0	2	40	159	186	220	256	302	326	384	404	397	453	448	486	515	544	595	669	706	734
Long-Term Debt
Liabilities	7	13	17	13	13	13	13	13	13	13				393	580	731	943	1,115	1,367	1,681	1,895	880	1,107	1,463	1,563	982	1,001	1,119	1,532	1,860	1,963
Stockholders' Equity	-7	-13	13	11	11	6	-0	-2	-8	-11	-15	-20	-68	-288	-521	-684	-899	-1,067	-1,201	-1,413	-1,642	-502	-772	-1,169	-1,031	-605	-839	-1,073	-1,437	-1,638


Income Statement ($'000)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-11-30	2019-02-28	2019-05-31
Revenue	0	0	0	0	0	0	0	0	0	0	0	0			5								1	0
Cost of Revenue															-2								0	0
Gross Profit															3	13	1	1	1	5	2	0	0	0
R&D															146	32	554	25	16	56	73	67	53	104	48	41	111	218	34	64	15
SG&A	0	5	3	1	0	5	6	2	6	3	4	5	48		70	52	73	59	42	68	44	51	121	183	54	34	80	67	24	36	57
Tax
Net Income	-4	-6	-4	-2	0	-1	-6	-2	-6	-2	-4	-5	-48	-273	-419	-292	-1,029	-480	-296	-334	-279	-1,060	-305	394	-833	-181	-296	-236	-128	-391	-144


Cash Flow ($'000)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-11-30	2019-02-28	2019-05-31
Cash Operating	-2	-9	0	-7	0	-5	-6	-2	-6	-3	-1	0	-1	-20	-203	-92	-98	-65	-175	-84	-123	-280	-157	-194	-108	-225	-85	-31		-142
Cash Investing	0	0	0	0	0	0	0	0	0	0	0	0			86	-9	-19	-14	-1	-185	-15	0	-95	0						0	0
Cash Financing	2	9	30	1	0	0	0	0	0	0	0	0			145	75	122	74	186	285	149	360	142	254	366	6	0	16		250	33